Kyle Guse - Mar 2, 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
CFO, Gen Counsel and Secretary
Signature
/s/ Kyle Guse
Stock symbol
ATOS
Transactions as of
Mar 2, 2023
Transactions value $
$0
Form type
4
Date filed
3/6/2023, 03:10 PM
Previous filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +558K $0.00 558K Mar 2, 2023 Common Stock 558K $0.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date.